First case report of ensartinib in a patient with metastatic ALK rearranged lung cancer with ALK I1171N mutation: a case report

BACKGROUND: The acquired resistance to ALK tyrosine kinase inhibitors (TKIs) in ALK-rearranged NSCLC is associated with poor survival outcomes and poses distinct clinical challenges. It is essential to develop potential therapeutic strategies for overcoming resistance. CASE PRESENTATION: Here, we fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuang, Feng, Weineng, Deng, Yanming, Liang, Jianmiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979531/
https://www.ncbi.nlm.nih.gov/pubmed/36864442
http://dx.doi.org/10.1186/s12957-023-02935-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979531/
https://www.ncbi.nlm.nih.gov/pubmed/36864442
http://dx.doi.org/10.1186/s12957-023-02935-9

Ejemplares similares